Early trial tests how food affects new diabetes drug combo
NCT ID NCT07133399
Summary
This early-stage study aimed to understand how the body absorbs two different combinations of the drugs vicadrostat and empagliflozin. It also tested whether taking the drugs with food changes how they work in the body. The study involved 32 healthy adult volunteers who each received the drug combinations in a specific order.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CRS Clinical Research Services Mannheim GmbH
Mannheim, 68167, Germany
Conditions
Explore the condition pages connected to this study.